Drug Pipeline

NP137 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
0
Recruiting
3
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-21 NCT05546879
Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in…		 date change Completion pushed: 2027-03-15 -> 2029-03-19
Active Studies by Phase
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05605496 NP137 Clinical and Biological Activities Assessment in Patients With Advanced/Metastatic… Advanced Solid Tumors Active, Not Recruiting
Phase 1
NCT06203821 Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer Pancreatic Cancer Not Yet Recruiting
NCT05546879 Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in… Hepatocellular Carcinoma Active, Not Recruiting
Sponsors Running NP137 Trials
University Hospital, Grenoble (1) Centre Leon Berard (1) Aram Hezel (1)
Disease Areas
Liver Cancer (1) Pancreatic Cancer (1)
Get alerts when NP137 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free